Table 1 Patient characteristics of all registered patients (n = 19)
Variable | Value (N = 19) |
|---|---|
Age [years] | |
Median (Min–Max), N = 19 | 68 (45–82) |
Gender | |
F | 3 (16%) |
M | 16 (84%) |
T stage | |
1 | 2 (11%) |
2 | 4 (21%) |
3 | 9 (47%) |
4 | 4 (21%) |
N stage | |
0 | 16 (84%) |
1 | 3 (16%) |
M stage | |
0 | 17 (89%) |
1 | 2 (11%) |
Total Child-Pugh score | |
5 | 11 (58%) |
6 | 4 (21%) |
7 | 3 (16%) |
8 | 1 (5%) |
WHO performance status | |
0 | 10 (53%) |
1 | 7 (37%) |
2 | 2 (11%) |
BCLC classification | |
0 | 1 (5%) |
A | 1 (5%) |
B | 10 (53%) |
C | 7 (37%) |
Vascular invasion | |
Yes | 8 (44%) |
No | 9 (50%) |
Unknown | 1 (6%) |
Missing | 1 |
Previous therapies (more than 1 possible) | |
TACE | 2 (11%) |
TAE | 1 (5%) |
PEI | 0 |
Local thermal ablation | 1 (5%) |
Liver resection | 2 (11%) |
Systemic treatment | 3 (16%) |
Other | 0 |
Longest diameter of largest lesion [mm] | |
Median (Min–Max), N = 19 | 86 (18–230) |
Gross tumor volume [ml] | |
Median (Min–Max), N = 19 | 340 (10–3582) |
Total liver volume [ml] | |
Median (Min–Max), N = 19 | 2136 (948–3400) |
Residual liver volume [ml] | |
Median (Min–Max), N = 19 | 1630 (906–2283) |
Etiology of underlying liver disease (more than 1 possible) | |
Hepatitis B | 1 (5%) |
Hepatitis C | 2 (11%) |
Alcohol | 14 (74%) |
Unknown | 3 (16%) |